Cargando…
P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431291/ http://dx.doi.org/10.1097/01.HS9.0000847064.38588.9b |
_version_ | 1784780013932904448 |
---|---|
author | DeAngelo, D. J. Pullarkat, V. Piris-Villaespesa, M. George, T. I. Patel, J. L. Ustun, C. Bose, P. Heaney, M. L. Pilla, A. Massaro, M. Exter, B. Jolin, H. A. Mikhak, Z. Tashi, T. |
author_facet | DeAngelo, D. J. Pullarkat, V. Piris-Villaespesa, M. George, T. I. Patel, J. L. Ustun, C. Bose, P. Heaney, M. L. Pilla, A. Massaro, M. Exter, B. Jolin, H. A. Mikhak, Z. Tashi, T. |
author_sort | DeAngelo, D. J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9431291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94312912022-08-31 P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS DeAngelo, D. J. Pullarkat, V. Piris-Villaespesa, M. George, T. I. Patel, J. L. Ustun, C. Bose, P. Heaney, M. L. Pilla, A. Massaro, M. Exter, B. Jolin, H. A. Mikhak, Z. Tashi, T. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431291/ http://dx.doi.org/10.1097/01.HS9.0000847064.38588.9b Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters DeAngelo, D. J. Pullarkat, V. Piris-Villaespesa, M. George, T. I. Patel, J. L. Ustun, C. Bose, P. Heaney, M. L. Pilla, A. Massaro, M. Exter, B. Jolin, H. A. Mikhak, Z. Tashi, T. P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS |
title | P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS |
title_full | P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS |
title_fullStr | P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS |
title_full_unstemmed | P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS |
title_short | P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS |
title_sort | p1049: a phase 2 study of bezuclastinib (cgt9486), a novel, highly selective, potent kit d816v inhibitor, in adults with advanced systemic mastocytosis (apex): methods, baseline data, and early insights |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431291/ http://dx.doi.org/10.1097/01.HS9.0000847064.38588.9b |
work_keys_str_mv | AT deangelodj p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT pullarkatv p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT pirisvillaespesam p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT georgeti p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT pateljl p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT ustunc p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT bosep p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT heaneyml p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT pillaa p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT massarom p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT exterb p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT jolinha p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT mikhakz p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights AT tashit p1049aphase2studyofbezuclastinibcgt9486anovelhighlyselectivepotentkitd816vinhibitorinadultswithadvancedsystemicmastocytosisapexmethodsbaselinedataandearlyinsights |